Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Arends TJ"" wg kryterium: Autor


Wyświetlanie 1-10 z 10
Tytuł :
Reply to Sławomir Poletajew, Piotr Radziszewski, Juan Palou's Letter to the Editor re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52.
Autorzy :
Arends TJ; Radboud University Medical Centre, Nijmegen, The Netherlands.
Witjes JA; Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
European urology [Eur Urol] 2017 Jan; Vol. 71 (1), pp. e31-e32. Date of Electronic Publication: 2016 Jul 15.
Typ publikacji :
Letter; Comment
MeSH Terms :
Mitomycin*
Urinary Bladder Neoplasms*
Adjuvants, Immunologic ; Administration, Intravesical ; BCG Vaccine ; Bacillus ; Humans
Opinia redakcyjna
Tytuł :
Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.
Autorzy :
Arends TJ; Radboud University Medical Centre, Nijmegen, The Netherlands.
Nativ O; Bnai-Zion Hospital, Haifa, Israel.
Maffezzini M; Ente Ospedaliero Ospedali Galliera, Genova, Italy.
de Cobelli O; Istituto Europeo di Oncologia, Milan, Italy.
Canepa G; Ente Ospedaliero Ospedali Galliera, Genova, Italy.
Verweij F; IRCCS Multimedica, Milan, Italy.
Moskovitz B; Bnai-Zion Hospital, Haifa, Israel.
van der Heijden AG; Radboud University Medical Centre, Nijmegen, The Netherlands.
Witjes JA; Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
European urology [Eur Urol] 2016 Jun; Vol. 69 (6), pp. 1046-52. Date of Electronic Publication: 2016 Jan 20.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Hyperthermia, Induced*
Adjuvants, Immunologic/*therapeutic use
Antibiotics, Antineoplastic/*therapeutic use
BCG Vaccine/*therapeutic use
Carcinoma in Situ/*therapy
Carcinoma, Papillary/*therapy
Mitomycin/*therapeutic use
Urinary Bladder Neoplasms/*therapy
Administration, Intravesical ; Aged ; Carcinoma in Situ/pathology ; Carcinoma, Papillary/pathology ; Combined Modality Therapy ; Disease Progression ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Muscle, Smooth/pathology ; Neoplasm Invasiveness ; Prospective Studies ; Risk Factors ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł :
The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
Autorzy :
Bruins HM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: .
Aben KK; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands; Radboud Institute for Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, The Netherlands.
Arends TJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Witjes AJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
Urologic oncology [Urol Oncol] 2016 Apr; Vol. 34 (4), pp. 166.e1-6. Date of Electronic Publication: 2015 Dec 15.
Typ publikacji :
Journal Article
MeSH Terms :
Urinary Bladder Neoplasms/*diagnosis
Urinary Bladder Neoplasms/*surgery
Aged ; Cystectomy/methods ; Cystectomy/mortality ; Female ; Humans ; Male ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Staging ; Netherlands/epidemiology ; Survival Rate ; Time Factors ; Treatment Outcome ; Urinary Bladder Neoplasms/mortality ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia.
Autorzy :
Arends TJ; Department of Urology, Radboud University Medical Centre, Geert Grooteplein zuid 10, 6525 GA, Nijmegen, The Netherlands. Tom.arends@radboudumc.nl.
Falke J; Department of Urology, Radboud University Medical Centre, Geert Grooteplein zuid 10, 6525 GA, Nijmegen, The Netherlands. .
Lammers RJ; Department of Urology, Radboud University Medical Centre, Geert Grooteplein zuid 10, 6525 GA, Nijmegen, The Netherlands. .
Somford DM; Canisius Wilhelmina Ziekenhuis, Weg door Jonkerbos 100, 6532 SZ, Nijmegen, The Netherlands. .
Hendriks JC; Biostatistician, Department for Health Evidence, Radboud University Medical Centre, Geert Grooteplein zuid 10, 6525 GA, Nijmegen, The Netherlands. .
de Weijert MC; Department of Urology, Radboud University Medical Centre, Geert Grooteplein zuid 10, 6525 GA, Nijmegen, The Netherlands. .
Arentsen HC; Department of Urology, Radboud University Medical Centre, Geert Grooteplein zuid 10, 6525 GA, Nijmegen, The Netherlands. .
van der Heijden AG; Department of Urology, Radboud University Medical Centre, Geert Grooteplein zuid 10, 6525 GA, Nijmegen, The Netherlands. .
Oosterwijk E; Department of Urology, Radboud University Medical Centre, Geert Grooteplein zuid 10, 6525 GA, Nijmegen, The Netherlands. .
Alfred Witjes J; Department of Urology, Radboud University Medical Centre, Geert Grooteplein zuid 10, 6525 GA, Nijmegen, The Netherlands. .
Pokaż więcej
Źródło :
World journal of urology [World J Urol] 2015 Oct; Vol. 33 (10), pp. 1411-7. Date of Electronic Publication: 2014 Dec 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Transitional Cell/*therapy
Cytokines/*urine
Hyperthermia, Induced/*methods
Mitomycin/*administration & dosage
Urinary Bladder Neoplasms/*therapy
Administration, Intravesical ; Aged ; Aged, 80 and over ; Antibiotics, Antineoplastic/administration & dosage ; Biomarkers, Tumor/urine ; Carcinoma, Transitional Cell/pathology ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Humans ; Instillation, Drug ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Pharmacokinetic, Pharmacodynamic, and Activity Evaluation of TMX-101 in a Multicenter Phase 1 Study in Patients With Papillary Non-Muscle-Invasive Bladder Cancer.
Autorzy :
Arends TJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Lammers RJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Falke J; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Rustighini I; Telormedix SA, Bioggio, Switzerland.
Pozzi R; Telormedix SA, Bioggio, Switzerland.
Ravic M; Pharma Integra Ltd, Wimbledon, London, England, UK.
Eisenhardt A; Pur/r Praxisklinik Urologie, Nordrhein-Westfalen, Germany.
Vergunst H; Department of Urology, Canisius-Wilhelmina Ziekenhuis, Nijmegen, The Netherlands.
Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Clinical genitourinary cancer [Clin Genitourin Cancer] 2015 Jun; Vol. 13 (3), pp. 204-9.e2. Date of Electronic Publication: 2014 Dec 31.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Multicenter Study
MeSH Terms :
Aminoquinolines/*administration & dosage
Antineoplastic Agents/*administration & dosage
Carcinoma, Renal Cell/*drug therapy
Kidney Neoplasms/*drug therapy
Administration, Intravesical ; Aminoquinolines/adverse effects ; Aminoquinolines/pharmacokinetics ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/pharmacokinetics ; Carcinoma, Renal Cell/pathology ; Carcinoma, Renal Cell/surgery ; Cystoscopy ; Dose-Response Relationship, Drug ; Female ; Humans ; Imiquimod ; Interleukin 1 Receptor Antagonist Protein/urine ; Kidney Neoplasms/pathology ; Kidney Neoplasms/surgery ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Management of low-risk and intermediate-risk non-muscle-invasive bladder carcinoma.
Autorzy :
Weijers Y; Department of Urology, RadboudUMC, PO Box 9101, Nijmegen 6500 HB, The Netherlands.
Arentsen HC; Department of Urology, RadboudUMC, PO Box 9101, Nijmegen 6500 HB, The Netherlands.
Arends TJ; Department of Urology, RadboudUMC, PO Box 9101, Nijmegen 6500 HB, The Netherlands.
Witjes JA; Department of Urology, RadboudUMC, PO Box 9101, Nijmegen 6500 HB, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2015 Apr; Vol. 29 (2), pp. 219-25, vii.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Disease Management*
Urinary Bladder Neoplasms/*diagnosis
Urinary Bladder Neoplasms/*therapy
Disease Progression ; Neoplasm Grading ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Urinary Bladder Neoplasms/mortality
Czasopismo naukowe
Tytuł :
Combined chemohyperthermia: 10-year single center experience in 160 patients with nonmuscle invasive bladder cancer.
Autorzy :
Arends TJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2014 Sep; Vol. 192 (3), pp. 708-13. Date of Electronic Publication: 2014 Apr 01.
Typ publikacji :
Journal Article
MeSH Terms :
Hyperthermia, Induced*
Antibiotics, Antineoplastic/*therapeutic use
Epirubicin/*therapeutic use
Mitomycin/*therapeutic use
Urinary Bladder Neoplasms/*therapy
Adult ; Aged ; Aged, 80 and over ; Combined Modality Therapy ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/prevention & control ; Prospective Studies ; Time Factors ; Urinary Bladder Neoplasms/drug therapy
Czasopismo naukowe
Tytuł :
Radical cystectomy in a Dutch University hospital: long-term outcomes and prognostic factors in a homogeneous surgery-only series.
Autorzy :
Bruins HM; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Arends TJ; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Pelkman M; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
van der Heijden AG; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Witjes JA; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Clinical genitourinary cancer [Clin Genitourin Cancer] 2014 Jun; Vol. 12 (3), pp. 190-5. Date of Electronic Publication: 2013 Nov 12.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Transitional Cell/*secondary
Carcinoma, Transitional Cell/*surgery
Urinary Bladder Neoplasms/*surgery
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Transitional Cell/mortality ; Cystectomy ; Disease-Free Survival ; Female ; Hospitals, University ; Humans ; Kaplan-Meier Estimate ; Lymph Node Excision ; Lymphatic Metastasis ; Male ; Middle Aged ; Netherlands ; Prognosis ; Proportional Hazards Models ; Treatment Outcome ; Urinary Bladder Neoplasms/mortality ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Expert review: an update in current and developing intravesical therapies for non-muscle-invasive bladder cancer.
Autorzy :
van Lingen AV; Department of Urology, Radboud University Medical Center, Geert Grooteplein zuid 10, 6525GA Nijmegen, The Netherlands.
Arends TJ
Witjes JA
Pokaż więcej
Źródło :
Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2013 Nov; Vol. 13 (11), pp. 1257-68.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antineoplastic Agents/*administration & dosage
Urinary Bladder Neoplasms/*drug therapy
Urinary Bladder Neoplasms/*pathology
Administration, Intravesical ; Humans ; Neoplasm Invasiveness
Czasopismo naukowe
Tytuł :
Multigranular exocytosis of Weibel-Palade bodies in vascular endothelial cells.
Autorzy :
Valentijn KM; Department of Molecular Cell Biology, Section Electron Microscopy, Leiden University Medical Center, Leiden, The Netherlands.
van Driel LF
Mourik MJ
Hendriks GJ
Arends TJ
Koster AJ
Valentijn JA
Pokaż więcej
Źródło :
Blood [Blood] 2010 Sep 09; Vol. 116 (10), pp. 1807-16. Date of Electronic Publication: 2010 May 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Exocytosis*
Endothelial Cells/*metabolism
Weibel-Palade Bodies/*metabolism
von Willebrand Factor/*metabolism
Cell Line ; Endothelial Cells/drug effects ; Endothelial Cells/ultrastructure ; Fluorescein-5-isothiocyanate/chemistry ; Humans ; Microscopy, Electron, Scanning ; Microscopy, Electron, Transmission ; Microscopy, Fluorescence ; Tetradecanoylphorbol Acetate/pharmacology ; von Willebrand Factor/chemistry
Czasopismo naukowe
    Wyświetlanie 1-10 z 10

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies